Meridian Bioscience (VIVO) 10-Q2004 Q1 Quarterly report

Filed: 13 Feb 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Bad

New words: added, agency, application, ARB, area, assessed, begun, billing, bovine, Bulletin, buying, calendar, call, carrying, case, charged, clearance, commodity, complement, consumption, continental, country, cow, criteria, critical, delivery, Department, dominant, driven, enable, encephalopathy, equal, experiencing, failure, FIN, fourth, front, hand, Health, hoofed, HpSA, human, ii, ImmunoCardSTAT, imposition, incurred, Index, influenza, initiated, Inspector, intellectual, intended, involve, key, launch, leverage, mad, million, mind, modest, monetary, monitor, move, movement, multiple, National, negative, Note, notified, notional, order, ownership, penetration, platform, Platinum, point, position, positive, previously, promulgated, protected, rapid, recapture, recombinant, recouped, redeemed, redemption, Regulatory, renew, resolve, resume, ruminant, select, serve, sheep, Sheet, source, sourced, sourcing, specimen, spongiform, Subpart, subside, SUBSIDIARIESConsolidated, thereof, transport, trend, UK, unamortized, USDA, vaccine, veterinary

Removed: Activity, addressing, applied, assuming, beginning, Binax, collaboration, commercialize, construction, conversion, converted, Cryptosporidium, demutualization, detect, diluted, Direct, distribute, distributing, environment, excluding, exclusive, executed, execution, extensive, fixed, Flu, gain, geographic, Giardia, global, granted, guarantor, higher, insurance, internally, legal, loan, matured, maturity, measurement, met, minimum, Modified, mortgage, obtain, OraSure, organization, planned, presented, Prospective, quarterly, recent, refinanced, reflect, relating, reserve, restated, Restatement, Retroactive, review, sell, significantly, size, strong, substantial, substantiated, Supply, timing, visit, wind, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

VIVO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

Certification of Chief Executive Officer and Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing with the Securities and Exchange Commission of the Quarterly Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2003 (the “Report”), the undersigned officers of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:

	1.		The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and

	2.		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ William J. Motto

William J. Motto
Chairman of the Board and
Chief Executive Officer
February 13, 2004

/s/ Melissa Lueke

Melissa Lueke
Vice President and
Chief Financial Officer
February 13, 2004

Page 23 of 23